Mesalamine Induced Pneumonitis [PDF]
C. Rosse, C. Schmitt, B. Rai
openaire +1 more source
Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis [PDF]
Michael F. Picco+3 more
openalex +1 more source
Validation of HPLC, DPPH and nitrosation methods for mesalamine determination in pharmaceutical dosage forms [PDF]
Janice Aparecida Rafael+5 more
openalex +1 more source
MMX mesalamine induces remission of mild-to-moderate ulcerative colitis in patients who have changed directly from other oral 5-ASA therapies and in those who have not previously received or who have discontinued 5-ASA: A combined analysis of two phase III studies [PDF]
G Lichtenstein+9 more
openalex +1 more source
INTRODUCTION. Oral mesalazine (5-aminosalicylic acid) products are commonly used to treat inflammatory bowel disease, in particular, ulcerative colitis.
S. Yu. Serebrova+4 more
doaj +1 more source
Mesalamine prevents dysplasia in patients with inflammatory bowel disease [PDF]
Ilan Aharoni+4 more
openalex +1 more source
A novel, hydrogen sulfide-releasing mesalamine derivative (ATB-429) exhibits enhanced anti-inflammatory and analgesic activity in experimental colitis [PDF]
Jennifer Wallace+3 more
openalex +1 more source